Schedule 13G ownership disclosure

VTV THERAPEUTICS INC

Class A Common Stock, $0.01 par value per share · CUSIP: 918385204

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Invus Public Equities, L.P.

    Shares: 345,926.00 · Class: 8.4%

  • Invus Public Equities Advisors, LLC

    Shares: 345,926.00 · Class: 8.4%

  • Invus Global Management, LLC

    Shares: 345,926.00 · Class: 8.4%

  • Siren, L.L.C.

    Shares: 345,926.00 · Class: 8.4%

  • Avicenna Life Sci Master Fund LP

    Shares: 47,172.00 · Class: 1.2%

  • Avicenna Life Sci Master GP LLC

    Shares: 47,172.00 · Class: 1.2%

  • Ulys, L.L.C.

    Shares: 47,172.00 · Class: 1.2%

  • Raymond Debbane

    Shares: 393,098.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002005369-25-000058
Form type
SCHEDULE 13G/A
Filer
Invus Global Management, LLC
CIK
CIK 2005369
Filed
Nov 12, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub